Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
Valeria Fumagalli, Micol Ravà, Davide Marotta, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 633-643
Open Access | Times Cited: 24

Showing 24 citing articles:

Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans
Shirin Kalimuddin, C Tham, Yvonne Fu Zi Chan, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 2
S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines
Yong‐Sik Bong, David Alan Brown, Ezra Chung, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Immunity against conserved and non-conserved Spike epitopes after COVID-19 booster vaccination provides long-term protection against symptomatic Omicron infections
Heiko Pfister, Carsten Uhlig, Zsuzsanna Mayer, et al.
Research Square (Research Square) (2025)
Open Access
Distinct CD8+ T-cell types Associated with COVID-19 Severity in Unvaccinated HLA-A2+ Patients
Kazuya Masuda, Sho Iketani, Lihong Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
T cell-mediated protection in absence of virus neutralizing antibodies
Yeranddy A. Alpízar, Kai Dallmeier
Nature Microbiology (2025)
Closed Access
COVID-19 mRNA vaccines are effective at stopping a nosy virus
Uxue Beloki, Laura Salaberry, Carla Ortuño-Moya, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102458-102458
Closed Access
A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model
Fengyu Chi, Xu Zhang, Dong Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates
Prakash D. Jadhav, Xueying Liang, Ahmadullah Ansari, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology
Jae‐Kwan Kim, A. V. Kachko, Prabhuanand Selvaraj, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner
Moe Kobayashi, Nobuyuki Kobayashi, Koichiro Deguchi, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Considering the host in host–pathogen interactions

Nature Microbiology (2024) Vol. 9, Iss. 5, pp. 1149-1149
Open Access | Times Cited: 2
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy
Rita C. Acúrcio, Ron Kleiner, Daniella Vaskovich‐Koubi, et al.
Advanced Science (2024) Vol. 11, Iss. 40
Open Access | Times Cited: 2
Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2
Hongwei Liu, Terza Brostoff, Ana Ramírez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Antibodies and complement are key drivers of thrombosis
Konstantin Stark, Badr Kilani, Sven Stockhausen, et al.
Immunity (2024) Vol. 57, Iss. 9, pp. 2140-2156.e10
Closed Access | Times Cited: 1
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
Asia‐Sophia Wolf, K. H. Bjørlykke, Hilde S Ørbo, et al.
EBioMedicine (2024) Vol. 108, pp. 105317-105317
Open Access | Times Cited: 1
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
Charlie Fricke, Lorenz Ulrich, Jana Kochmann, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102360-102360
Open Access | Times Cited: 1
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice
James Brett Case, Shilpa Sanapala, Carly Dillen, et al.
Cell Host & Microbe (2024)
Open Access | Times Cited: 1
Regional specialization within the mammalian respiratory immune system
David P. Hoytema van Konijnenburg, Peter A. Nigrovic, Ivan Zanoni
Trends in Immunology (2024) Vol. 45, Iss. 11, pp. 871-891
Closed Access | Times Cited: 1
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.
Cansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The power of memory T cells minus antibodies
Thi H. O. Nguyen, Katherine Kedzierska
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 594-595
Closed Access
Design of targeted antiviral polypeptides specific to SARS-CoV-2. Challenges and prospects
О. Н. Шилова, Е. С. Шилов, Sergey M. Deyev
Russian Chemical Reviews (2024) Vol. 93, Iss. 6, pp. RCR5128-RCR5128
Closed Access
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer
Amy Body, Luxi Lal, Sriganesh Srihari, et al.
Vaccine (2024), pp. 126547-126547
Open Access
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
Rossella Brandi, Alessia Paganelli, Raffaele D’Amelio, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1418-1418
Open Access
Distinct Requirements for CD4+ T Cell Help for Immune Responses Induced by mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines
L. R. Yong, Claire Hutchings, Eleanor Barnes, et al.
European Journal of Immunology (2024)
Closed Access
Page 1

Scroll to top